JUSTYNA KELLY - 09 Dec 2021 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Chief Operating Officer
Signature
/s/ William L. Demers, by Power of Attorney for Justyna Kelly
Issuer symbol
PNT
Transactions as of
09 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 10:27:38 UTC
Previous filing
10 Dec 2021
Next filing
31 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +70,000 $0.000000 70,000 09 Dec 2021 Common Stock 70,000 $6.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on December 9, 2022 with the remaining 75% vesting in three equal annual installments thereafter. Notwithstanding the foregoing, upon any Sale Event (as defined in the Issuer's 2021 Plan), any outstanding stock options shall automatically become fully vested and exercisable as of the effective time of the Sale Event.